Harmony Biosciences Aktie
WKN DE: A2QBSF / ISIN: US4131971040
|
29.10.2024 14:37:05
|
Harmony Biosciences Holdings, Inc Q3 Profit Increases, Beats Estimates
(RTTNews) - Harmony Biosciences Holdings, Inc (HRMY) revealed a profit for its third quarter that increased from the same period last year and beat the Street estimates.
The company's earnings totaled $46.09 million, or $0.79 per share. This compares with $38.46 million, or $0.63 per share, in last year's third quarter.
Excluding items, Harmony Biosciences Holdings, Inc reported adjusted earnings of $59.6 million or $1.03 per share for the period.
Analysts on average had expected the company to earn $0.66 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 16.1% to $186.04 million from $160.27 million last year.
Harmony Biosciences Holdings, Inc earnings at a glance (GAAP) :
-Earnings (Q3): $46.09 Mln. vs. $38.46 Mln. last year. -EPS (Q3): $0.79 vs. $0.63 last year. -Revenue (Q3): $186.04 Mln vs. $160.27 Mln last year.
-Guidance: Full year revenue guidance: $700 mln - $720 mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Harmony Biosciencesmehr Nachrichten
|
03.11.25 |
Ausblick: Harmony Biosciences verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Harmony Biosciencesmehr Analysen
Aktien in diesem Artikel
| Harmony Biosciences | 32,98 | 3,65% |
|